Video summary

Hologic’s Proprietary Real-Time TMA

Main summary

Key takeaways

Science and Nature

Scientific concepts / discoveries / nature phenomena

  • Infectious pathogen detection via genetic sequences

    • Pathogens (e.g., viruses, bacteria, fungi, parasites) are identified by unique genetic sequences.

  • Realtime Transcription Mediated Amplification (rTMA)

    • A rapid, sensitive, and specific molecular assay technology.
    • Detects target sequences from pathogens with either RNA or DNA genomes.
      • If the target genome is DNA, it is transcribed to RNA as part of the workflow.

Methodology / workflow (rTMA) — single-tube, fully automated

Platform & automation

  • Conducted in one tube on a fully automated Panther system.

Phase 1: Target capture (from patient specimen)

  • Patient nucleic acids are lysed to expose and stabilize nucleic acids.
  • Target-specific capture oligonucleotides hybridize to regions adjacent to the target sequences.
  • T7 promoter-containing primers (oligonucleotides) are also hybridized to the target to enable later amplification.
  • Magnetic microparticles capture the hybridized target complexes.
  • The mixture is magnetically isolated and washed to remove unbound nucleic acids and potential inhibitors.

Phase 2: Isothermal exponential amplification (enzyme-driven, transcription-mediated)

  • Uses two enzymes:

    • Reverse transcriptase
      • Converts RNA targets into complementary DNA (cDNA).
      • Digests the original RNA strand from the RNA/DNA duplex, leaving single-stranded DNA that includes the T7 promoter.
      • Produces a template that enables further amplification cycles.
    • T7 RNA polymerase
      • Transcribes the double-stranded DNA template to produce multiple RNA amplicons.

  • The cycle generates exponential amplification of RNA.

Phase 3: Real-time fluorescence detection

  • Detection uses fluorescently labeled single-stranded nucleic acid “torches” (auto-generated subtitle likely means reporter probes/fluorescent oligos).
  • Each probe contains a fluorophore and a quencher.
  • Probes emit fluorescence only when bound to RNA amplicons:
    • Binding separates the quencher from the fluorophore.
  • Fluorescence increases as more amplicons are produced.
  • Time-to-threshold (when fluorescence crosses a set level) is inversely proportional to the starting pathogen concentration.

Key claimed outcome

  • Accurate, precise, sensitive identification and quantitation of infectious pathogens using:
    • Highly specific target capture
    • Exponential amplification
    • Real-time detection
  • Intended to set a “new standard in disease testing.”

Researchers or sources featured

  • No specific researchers, institutions, or external sources are named in the provided subtitles.

Original video